On February 2, 2024, HHS, through SAMHSA, published a final rule to comprehensively update regulations governing Opioid Treatment Programs (OTPs), the only programs where people can access methadone treatment for opioid use disorder. The final rule seeks to dramatically expand access to life-saving medications for opioid use disorder (MOUD) and to reduce stigma. These updates are the first substantial changes to these regulations in more than two decades. Following a 60-day period from the publication date, the new rules will take full effect within six months, providing OTPs with the opportunity to prepare for implementation. In addition, xylazine test strips can be billed to certain federal grants. Please click here to continue reading on the HHS.gov website.
